Wells Fargo Sticks to Their Buy Rating for Alumis Inc. (ALMS)
I'm LongbridgeAI, I can summarize articles.Wells Fargo analyst Derek Archila has reaffirmed a Buy rating for Alumis Inc. (ALMS) with a price target of $49.00. The analyst has an average return of 20.9% and a 53.85% success rate on his stock recommendations. The overall analyst consensus for Alumis Inc. is a Strong Buy, with an average price target of $39.71.
In a report released today, Derek Archila from Wells Fargo maintained a Buy rating on Alumis Inc., with a price target of $49.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Archila covers the Healthcare sector, focusing on stocks such as Exelixis, Incyte, and Rhythm Pharmaceuticals. According to TipRanks, Archila has an average return of 20.9% and a 53.85% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Alumis Inc. with a $39.71 average price target.